Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0358419940370061246
Korean Journal of Obstetrics and Gynecology
1994 Volume.37 No. 6 p.1246 ~ p.1254
Clinical Effects of Recombinant Human G-CSF (Neutrogin) on Neutropenia Induced by the Cancer Chemotherapy for Gynecologic Malignancy
ÀÌÈ¿Ç¥
¼Û¿ë»ó/¹®Çý¼º/±èÇö¿­/¹Ú³ëÇö/°­¼ø¹ü
Abstract
This study is nudertaken to investigate the clinical effects of Neutrogin (recombinant human granulocyte-colony stimulating factor) in 25 patients with ovarian cancer and endometrial cancer who received two courses of CAP chemotherapy.
In the first course of chemotherapy as a control course, all patients were treated with CAP chemotherapy alone and during the second course, Neutrogin was given at a dose of 2¥ìg/kg/day subcutaneously for 14 days 24 hours after completion of
chemotherapy.
Neutrogin significantly increased the nadir count of leukocyte and absolute neutrophil and decreased the number of days per patient on which the absolute neutrophil count was 1,000/m* or less. The mean recovery time required for neutrophil to
greater
than 1,500/mm* after nadir were significantly decreased in the second course as compared with the first course. Each one patient experienced mild side effects of Neutrogin such as fever, bone pain and malaise and recovered without treatment.
These results were showed that Neutrogin was extremely effective and useful to treat chemotherapy induced leukopenia and to accelerate the recovery from these complications.
KEYWORD
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø